Klotho Neurosciences Inc.

NASDAQ: KLTO · Real-Time Price · USD
0.72
0.00 (0.19%)
At close: Aug 21, 2025, 11:20 AM

Klotho Neurosciences Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-5.54M -631.32K -574.37K -1.11M
Interest Income
n/a n/a n/a n/a
Pretax Income
-6.15M -707.46K -598.59K -1.11M
Net Income
-6.15M -707.46K -598.59K -1.11M
Selling & General & Admin
5.54M 631.32K 574.37K 1.11M
Research & Development
n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a
Operating Expenses
5.54M 631.32K 574.37K 1.11M
Interest Expense
356.6K 76.21K 24.37K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
5.54M 631.32K 574.37K 1.11M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
19.25M 1.04B 1.04B 1.04B
Shares Outstanding (Diluted)
19.25M 1.04B 1.04B 1.04B
EPS (Basic)
-0.32 -0.00 -0.00 -0.00
EPS (Diluted)
-0.32 -0.00 -0.00 -0.00
EBITDA
-5.79M -631.24K -574.23K -1.11M
EBIT
-5.79M -631.24K -574.23K -1.11M
Depreciation & Amortization
n/a n/a n/a n/a